Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.

Saved in:
Bibliographic Details
Title: Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
Authors: Magno L; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. l.magno@ucl.ac.uk., Lessard CB; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Martins M; Research Department of Structural and Molecular Biology, University College London, London, UK.; Present address: Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina de Lisboa, Lisbon, Portugal., Lang V; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK., Cruz P; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Asi Y; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK., Katan M; Research Department of Structural and Molecular Biology, University College London, London, UK., Bilsland J; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK., Lashley T; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK., Chakrabarty P; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Golde TE; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Whiting PJ; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. p.whiting@ucl.ac.uk.; Dementia Research Institute, UCL, London, UK. p.whiting@ucl.ac.uk.
Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Feb 02; Vol. 11 (1), pp. 16. Date of Electronic Publication: 2019 Feb 02.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30711010
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Magno+L%22">Magno L</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. l.magno@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Lessard+CB%22">Lessard CB</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Martins+M%22">Martins M</searchLink>; Research Department of Structural and Molecular Biology, University College London, London, UK.; Present address: Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Lang+V%22">Lang V</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Cruz+P%22">Cruz P</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Asi+Y%22">Asi Y</searchLink>; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Katan+M%22">Katan M</searchLink>; Research Department of Structural and Molecular Biology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bilsland+J%22">Bilsland J</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Lashley+T%22">Lashley T</searchLink>; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Chakrabarty+P%22">Chakrabarty P</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Golde+TE%22">Golde TE</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Whiting+PJ%22">Whiting PJ</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. p.whiting@ucl.ac.uk.; Dementia Research Institute, UCL, London, UK. p.whiting@ucl.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101511643%22">Alzheimer's research & therapy</searchLink> [Alzheimers Res Ther] 2019 Feb 02; Vol. 11 (1), pp. 16. <i>Date of Electronic Publication: </i>2019 Feb 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101511643 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1758-9193 (Electronic) <i>NLM ISO Abbreviation: </i>Alzheimers Res Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30711010
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13195-019-0469-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 16
    Titles:
      – TitleFull: Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Magno L
      – PersonEntity:
          Name:
            NameFull: Lessard CB
      – PersonEntity:
          Name:
            NameFull: Martins M
      – PersonEntity:
          Name:
            NameFull: Lang V
      – PersonEntity:
          Name:
            NameFull: Cruz P
      – PersonEntity:
          Name:
            NameFull: Asi Y
      – PersonEntity:
          Name:
            NameFull: Katan M
      – PersonEntity:
          Name:
            NameFull: Bilsland J
      – PersonEntity:
          Name:
            NameFull: Lashley T
      – PersonEntity:
          Name:
            NameFull: Chakrabarty P
      – PersonEntity:
          Name:
            NameFull: Golde TE
      – PersonEntity:
          Name:
            NameFull: Whiting PJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 02
              Text: 2019 Feb 02
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1758-9193
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Alzheimer's research & therapy
              Type: main
ResultId 1